Skip to main content
SLAS Europe 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Short Course
Short Course
On Demand
On Demand
Back

David T. Rodgers, PhD (he/him/his)

Senior Director Cell Therapy
Shoreline Biosciences, United States

Dr. David T. Rodgers is an accomplished scientist and Senior Director of Immunotherapy at Shoreline Biosciences. Originally from the UK, David obtained his Bachelor's degree in Microbiology and Immunology from Newcastle University and went on to pursue a PhD at the University of Glasgow, where he focused on small molecule drug development for autoimmunity. Following his doctoral studies, David joined the California Institute for Biomedical Research (Calibr; now part of The Scripps Research Institute) in 2014 as a postdoctoral fellow, where he developed antibody and cell therapy products, most notably a switchable CAR-T cell therapy that is now in phase 1 clinical trials.

Prior to joining Shoreline, David established an Infectious Disease & Immunology research group at Regulus Therapeutics that developed microRNA modulating drug candidates for a variety of disease indications. He has authored multiple patents and published numerous research papers in top-tier scientific journals. At Shoreline, David was one of the first research leaders to join the company. His innovative work in developing iPSC derived macrophage and NK cell therapies has the potential to transform cancer treatment globally.

Presentation(s):